Ronald Feitosa Pinheiro

Molecular International Prognostic Scoring System for Myelodysplastic Syndromes

Elsa Bernard, Heinz Tuechler, Peter L. Greenberg et al. · NEJM Evidence · 2022 · 813 citations · Full text

Medicine, Genetics, Hematology +16

Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes

Elsa Bernard, Yasuhito Nannya, Robert P. Hasserjian et al. · Nature Medicine · 2020 · 636 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

Molecular taxonomy of myelodysplastic syndromes and its clinical implications

Elsa Bernard, Robert P. Hasserjian, Peter L. Greenberg et al. · Blood · 2024 · 73 citations · Full text

Medicine, Hematology, Molecular Biology +16

<i>TLR4</i> deficiency upregulates TLR9 expression and enhances irinotecan‐related intestinal mucositis and late‐onset diarrhoea

Deysi Viviana Tenazoa Wong, Renata Brito Falcão Holanda, Aurilene Gomes Cajado et al. · British Journal of Pharmacology · 2021 · 31 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Severely impaired terminal erythroid differentiation as an independent prognostic marker in myelodysplastic syndromes

Abdullah Mahmood Ali, Yu-Min Huang, Ronald Feitosa Pinheiro et al. · Blood Advances · 2018 · 29 citations · Full text

Medicine, Hematology, Pathology +17